CRISCuris, Inc.

$14M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-28.4% YoY

Gross Profit

$2M93.9% margin

Operating Income

-$6M-314.5% margin

Net Income

-$10M-559.4% margin

EPS (Diluted)

$-5.96

QoQ Revenue Growth

-35.9%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$651,000

Balance Sheet

Total Assets

$55M

Total Liabilities

$69M

Stockholders' Equity

-$14M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	-28.4%
Gross Profit	$2M	$2M	-29.1%
Operating Income	-$6M	-$10M	+43.9%
Net Income	-$10M	-$11M	+8.0%

Revenue Segments

Contra Revenue

-$370,000

CRIS Q1 2019 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena